Want a glimpse of what the pharma info-pro’s life is all about? R & D Insight (RDI) is the authoritative source for worldwide pharmaceutical pipeline business intelligence monitoring all pertinent aspects of a drug’s life cycle from clinical development to product launch or discontinuation. Begun in 1995 as ADIS R&D Insight, it provides drug intelligence on over 15,000 developmental compounds and continuously monitors the pharmaceutical environment, increasing its database by 15% annually.
The Drexel subscription will be on both the native and OVID platforms, starting in January, with the OVID platform permitting cross-searching with other OVID-hosted medical databases. The Library will hopefully carry links to both versions, but I highly recommend you try the native interface to get the full benefit of this tool.
See the extended entry for additional notes on this great drug-info database…
